2) is an ADP that combines a TIMI risk score
of 0, a nonischemic EKG, and negative serial troponin measures at 0 and 2 h to identify patients at low risk for MACE at 30 days.
TIMI risk score
for ST-elevation myocardial infarctiona convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy.
He also talked about TIMI Risk Score
. Some patients whoa are already on Aspirin therapy but still have ACS, they are known as non-responders.
Also, obese patients tended to present with NSTEMIs having lower-risk features, as reflected in their TIMI risk scores
. The prevalence of a high TIMI risk score
was only 28.5% in obese patients, compared with 35.4% in overweight and 51.4% in lean patients.
Adjusted analyses incorporated clinical elements of the TIMI risk score
for unstable angina/NSTEMI, including age, recent aspirin use, multiple coronary risk factors, known coronary disease, and ST-segment deviation (18).
Currently, many risk scores are being used for this purpose such as TIMI risk score
, which requires multiple variables to be entered (1, 2).
We used a multivariable Coxproportionalhazards regression model to adjust for (a) TIMI risk score
covariates, as defined by age > 65 years, known coronary arterydisease, diabetes, hypertension, dyslipidemia, severe angina ([greater than or equal to] 2 episodes in 24h), ST changes [greater than or equal to]0.5 mm, and aspirin use; (b) other characteristics of interest: smoking, history of HF, creatinine clearance <60 mL/min (as defined by the Cockcroft-Gault equation); and (c) other biomarkers, including cTnI, BNP, myeloperoxidase (MPO), and high-sensitivity C-reactive protein (hsCRP).
Risk scoring and prognostication by means of the TIMI risk score
(23) (Table 1) for unstable angina or non-ST elevation myocardial infarction has recently been introduced and is widely implemented.
Patients with cardiac troponin results above cutoff by either of the 2 assays were significantly older; had more cardiovascular risk factors, more often a history of atherosclerotic diseases or events, and a higher TIMI risk score
; and more frequently received aspirin, [beta]-blockers, and other medical treatments.
The highest risk patients (recent MI, multivessel CAD, PAD, and highest TIMI risk score
) have the greatest benefit.
The TIMI risk score
for unstable angina/non-STelevation MI: A method for prognostication and therapeutic decision making.